In Heavy metal toxicity Heavy metal toxicity may occur as a result of industrial exposure, air or water pollution, foods, medicines, improperly coated food containers, or the ingestion of lead-based paints. As a result, the person who experiences it may have abdominal pain, nausea, vomiting, and diarrhea. B A L Injection is a medication used in the treatment of toxic exposure to arsenic, mercury, gold, and lead. It is injected into the bloodstream by a doctor or nurse to remove heavy metals and/or minerals from the body. B A L Injection relieves the symptoms of heavy metal toxicity by flushing out the toxic metals from your body as a waste.
It is not known whether it is safe to consume alcohol with B A L Injection. Please consult your doctor.
B A L Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
B A L Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
B A L Injection does not usually affect your ability to drive.
B A L Injection should be used with caution in patients with kidney disease. Dose adjustment of B A L Injection may be needed. Please consult your doctor.
B A L Injection is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More